{"nct_id":"NCT01627340","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus","status":"COMPLETED","status_verified_date":"2017-01","start_date":"2012-07-24","start_date_type":null,"primary_completion_date":"2013-12-18","primary_completion_date_type":"ACTUAL","completion_date":"2013-12-18","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}